
LYNX1 CAPITAL MANAGEMENT LP
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | GHRS | 10.41M | $132.16M |
![]() | CGEM | 8.96M | $92.77M |
![]() | TCRX | 8.02M | $8.02M |
![]() | CCCC | 7.10M | $13.56M |
![]() | STOK | 5.40M | $171.54M |
![]() | DNLI | 1.74M | $28.71M |
![]() | DTIL | 994K | $4.13M |
![]() | IMTX | 922K | $9.68M |
![]() | XNCR | 706K | $10.80M |
![]() | KRRO | 678K | $5.43M |
![]() | HOWL | 656K | $415.53K |
![]() | PASG | 624K | $7.36M |
![]() | APLT | 411K | $41.05K |
![]() | AGIO | 80K | $2.17M |
![]() | DSGN | 70K | $652.06K |
![]() | PRQR | 68K | $138.34K |
![]() | TRDA | 52K | $531.36K |
![]() | CGON | 32K | $1.31M |
![]() | GBIO | 25K | $142.00K |
![]() | MPLT | 13K | $236.72K |

GH Research PLC
GHRS
Shares Held
10.41M
Value
$132.16M

Cullinan Therapeutics, Inc.
CGEM
Shares Held
8.96M
Value
$92.77M

TScan Therapeutics, Inc.
TCRX
Shares Held
8.02M
Value
$8.02M

C4 Therapeutics, Inc.
CCCC
Shares Held
7.10M
Value
$13.56M

Stoke Therapeutics, Inc.
STOK
Shares Held
5.40M
Value
$171.54M

Denali Therapeutics Inc.
DNLI
Shares Held
1.74M
Value
$28.71M

Precision BioSciences, Inc.
DTIL
Shares Held
994K
Value
$4.13M

Immatics N.V.
IMTX
Shares Held
922K
Value
$9.68M

Xencor, Inc.
XNCR
Shares Held
706K
Value
$10.80M

Korro Bio, Inc.
KRRO
Shares Held
678K
Value
$5.43M

Werewolf Therapeutics, Inc.
HOWL
Shares Held
656K
Value
$415.53K

Passage Bio, Inc.
PASG
Shares Held
624K
Value
$7.36M

Applied Therapeutics, Inc.
APLT
Shares Held
411K
Value
$41.05K

Agios Pharmaceuticals, Inc.
AGIO
Shares Held
80K
Value
$2.17M

Design Therapeutics, Inc.
DSGN
Shares Held
70K
Value
$652.06K

ProQR Therapeutics N.V.
PRQR
Shares Held
68K
Value
$138.34K

Entrada Therapeutics, Inc.
TRDA
Shares Held
52K
Value
$531.36K

CG Oncology, Inc. Common stock
CGON
Shares Held
32K
Value
$1.31M

Generation Bio Co.
GBIO
Shares Held
25K
Value
$142.00K

MapLight Therapeutics, Inc.
MPLT
Shares Held
13K
Value
$236.72K
